A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: Exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects

Neuropharmacology

Volumn 48, Issue 5, 2005, Pages 706-719

  Herpfer, Inga ^a,b   Hunt, Stephen P ^a   Stanford, S Clare ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Desipramine; Light dark exploration box; Microdialysis; NK1 receptor; Noradrenaline; RX821002

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; DESIPRAMINE; HALOTHANE; NEUROKININ 1 RECEPTOR; NORADRENALIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENOTYPE; GROOMING; KNOCKOUT MOUSE; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

EID: 16244418381     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.12.016     Document Type: Article

References (61)

1. D. Allam, D. Girdlestone, and C. Garret Effects of the substance P antagonist RP67580 on neuronal activity in the rat locus coeruleus Br. J. Pharmacol. 107 1992 227P
2. J.M. Baraban, and G.K. Aghajanian Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists Neuropharmacology 19 1980 355 363
3. L. Bert, D. Rodier, I. Bougault, N. Allouard, G. Le-Fur, P. Soubrie, and R. Steinberg Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801 Synapse 43 2002 62 69
4. M. Brocco, A. Dekeyne, S. Veiga, S. Girardon, and M.J. Millan Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents Pharmacol. Biochem. Behav. 71 2002 667 680
5. H.J. Cheeseman, R.D. Pinnock, and G. Henderson Substance P excitation of rat locus coeruleus neurones Eur. J. Pharmacol. 94 1983 93 99
6. L.W. Chen, L.C. Wei, H.L. Liu, and Z.R. Rao Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat Brain Res. 873 2000 155 159
7. K.G. Commons, and R.J. Valentino Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus J. Comp. Neurol. 447 2002 82 97
8. J.N. Crawley Behavioral phenotyping of rodents Comp. Med. 53 2003 140 146
9. R.W. Clarke, and J. Harris RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors CNS Drug Rev. 8 2002 177 192
10. J.F. Cryan, O.F. O'Leary, S.H. Jin, J.C. Friedland, M. Ouyang, B.R. Hirsch, M.E. Page, A. Dalvi, S.A. Thomas, and I. Lucki Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors Proc. Natl Acad. Sci. U.S.A. 101 2004 8186 8191
11. J.W. Dalley, K. Mason, and S.C. Stanford Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone Psychopharmacology 127 1996 47 54
12. C. De Felipe, J.F. Herrero, J.A. O'Brien, J.A. Palmer, C.A. Doyle, A.J. Smith, J.M. Laird, C. Belmonte, F. Cervero, and S.P. Hunt Altered nociception, analgesia and aggression in mice lacking the receptor for substance P Nature 392 1998 394 397
13. J.M. Finlay, M.J. Zigmond, and E.D. Abercrombie Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam Neuroscience 64 1995 619 628
14. A.S. Fisher, R.J. Stewart, S.P. Hunt, and S.C. Stanford Functional differences in central noradrenergic function of NK1-/- and NK1+/+ mice? J. Psychopharmacol. 17 Suppl. 2003 A12
15. A.S. Fisher, S.P. Hunt, and S.C. Stanford Investigation of the functional activity of alpha2-adrenoceptors in NK1-/- and NK1+/+ mice J. Psychopharmacol. 18 Suppl. 2004 A71
16. N. Froger, A.M. Gardier, R. Moratalla, I. Alberti, I. Lena, C. Boni, C. De Felipe, N.M. Rupniak, S.P. Hunt, C. Jacquot, M. Hamon, and L. Lanfumey 5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization J. Neurosci. 21 2001 8188 8197
17. S.M. Géranton, D.J. Heal, and S.C. Stanford Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus Br. J. Pharmacol. 139 2003 1441 1448
18. 3H]RX-821002 binding to membranes and tissue sections Eur. J. Pharmacol. 310 1996 83 93
19. B.P. Guiard, C. Przybylski, J.P. Guilloux, I. Seif, N. Froger, C. De Felipe, S.P. Hunt, L. Lanfumey, and A.M. Gardier Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice J. Neurochem. 89 2004 54 63
20. N. Haddjeri, and P. Blier Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons Neuroreport 11 2000 1323 1327
21. N. Haddjeri, C. de Montigny, and P. Blier Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxytryptamine system Br. J. Pharmacol. 120 1997 865 875
22. D.J. Heal Phenylephrine-induced activity in mice as a measure of central alpha1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock Neuropharmacology 23 1984 1241 1251
23. Herpfer, I., Lieb, K. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs, in press.
24. P. Kalen, E. Rosegren, O. Lindvall, and A. Bjorkland Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation with behavioural activity state, effects of handling and tail-pinch Eur. J. Neurosci. 1 1989 181 188
25. R. Liu, Y. Ding, and G.K. Aghajanian Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus Neuropsychopharmacology 27 2002 329 340
26. Q.P. Ma, and C. Bleasdale Modulation of brain stem monoamines and gamma-aminobutyric acid by NK1 receptors in rats Neuroreport 13 2002 1809 1812
27. H. Maeno, H. Kiyama, and M. Tohyama Distribution of the substance P receptor (NK-1 receptor) in the central nervous system Brain Res. Mol. Brain Res. 18 1993 43 58
28. K. Mason, D.J. Heal, and S.C. Stanford The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty Pharmacol. Biochem. Behav. 60 1998 321 327
29. K.A. Maubach, K. Martin, G. Chicchi, T. Harrison, A. Wheeldon, C.J. Swain, M.J. Cumberbatch, N.M. Rupniak, and G.R. Seabrook Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus Neuroscience 109 2002 609 617
30. M. Mavridis, F.C. Colpaert, and M.J. Millan Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha1 as compared to alpha2 agonists and antagonists Brain Res. 562 1984 216 224
31. S. McLean, A. Ganong, P.A. Seymour, R.M. Snider, M.C. Desai, T. Rosen, D.K. Bryce, K.P. Longo, L.S. Reynolds, and G. Robinson Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor J. Pharmacol. Exp. Ther. 267 1993 472 479
32. R. McQuade, D. Creton, and S.C. Stanford Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis Psychopharmacology 145 1999 393 400
33. R. McQuade, and S.C. Stanford A microdialysis study of the noradrenergic response in rat frontal cortex and hypothalamus to a conditioned cue for aversive, naturalistic environmental stimuli Psychopharmacology 148 2000 201 208
34. R. Mead The design of experiments 1988 Cambridge University Press Cambridge, NY
35. M.J. Millan, F. Lejeune, G. De Nanteuil, and A. Gobert Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats J. Neurochem. 76 2001 1949 1954
36. 3H]noradrenaline in rat brain limbic structures Eur. J. Pharmacol. 256 1994 269 279
37. P. Murtra, A.M. Sheasby, S.P. Hunt, and C. De Felipe Rewarding effects of opiates are absent in mice lacking the receptor for substance P Nature 405 2000 180 183
38. A. Newman-Tancredi, J.P. Nicolas, V. Audinot, S. Gavaudan, L. Verriele, M. Touzard, C. Chaput, N. Richard, and M.J. Millan Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors Naunyn Schmiedebergs Arch. Pharmacol. 358 1998 197 206
39. K. Ogawa, T. Nabe, H. Yamamura, and S. Kohno Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats Eur. J. Pharmacol. 374 1999 285 291
40. J. Ogilvie, and R.W. Clarke Effect of RX 821002 at 5-HT1A-receptors in rabbit spinal cord in vivo Br. J. Pharmacol. 123 1998 1138 1142
41. V.N. Pashkov, and H.C. Hemmings Jr. The effects of general anesthetics on norepinephrine release from isolated rat cortical nerve Anesth. Analg. 95 2002 1274 1281
42. G. Paxinos, and K.B.J. Franklin The mouse brain in stereotaxic coordinates second ed. 2001 Academic Press London, UK
43. H.P. Rang, M.M. Dale, J.M. Ritter, and P.K. Moore Pharmacology fifth ed. 2003 Churchill Livingston London pp. 538-544
44. D.E. Redmond, and Y.H. Huang Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety Life Sci. 25 1979 2149 2162
45. R.J. Rodgers, and J.C. Cole Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test Eur. J. Pharmacol. 261 1994 321 325
46. N.M. Rupniak, E.C. Carlson, T. Harrison, B. Oates, E. Seward, S. Owen, C. de Felipe, S. Hunt, and A. Wheeldon Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice Neuropharmacology 39 2000 1413 1421
47. N.M. Rupniak, E.J. Carlson, J.K. Webb, T. Harrison, R.D. Porsolt, S. Roux, C. de Felipe, S.P. Hunt, B. Oates, and A. Wheeldon Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs Behav. Pharmacol. 12 2001 497 508
48. S. Sakurada, T. Orito, S. Furuta, H. Watanabe, J.I. Mobarakeh, K. Yanai, T. Watanabe, T. Sato, K. Onodera, C. Sakurada, and T. Sakurada Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors Pharmacol. Biochem. Behav. 74 2003 487 493
49. L. Santarelli, G. Gobbi, P.C. Debs, E.T. Sibille, P. Blier, R. Hen, and M.J. Heath Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function Proc. Natl Acad. Sci. U.S.A. 98 2001 1912 1917
50. L. Santarelli, G. Gobbi, P. Blier, and R. Hen Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1) J. Clin. Psychiatry 63 Suppl. 11 2002 11 17
51. M. Sauvage, and T. Steckler Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei - potential implication for arousal and attention Neuroscience 104 2001 643 652
52. H.E. Shannon, and S.C. Peters A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice J. Pharmacol. Exp. Ther. 255 1990 549 553
53. A. Soderpalm, F. Ehrenstrom, and B. Soderpalm The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings J. Neural. Transm. Gen. Sect. 100 1995 191 206
54. S.C. Stanford Central noradrenergic neurones and stress Pharmacol. Ther. 68 1995 297 342
55. S.C. Stanford Prozac: panacea or puzzle? Trends Pharmacol. Sci. 17 1996 150 154
56. R.J. Stewart, A.S. Fisher, S.P. Hunt, and S.C. Stanford Increased basal noradrenaline (NA) efflux in the frontal cortex and a modified response to atipamezole in the light-dark shuttle box, of NK1 receptor knockout mice 〈http://www.pa2online.org/Vol1Issue4abst133P.html〉 2004
57. 3H]prazosin binding is correlated with behavioral immobility Eur. J. Pharmacol. 420 2001 97 102
58. M. Suzuki, T. Matsuda, S. Asano, P. Somboonthum, K. Takuma, and A. Baba Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation Br. J. Pharmacol. 115 1995 703 711
59. R.J. Valentino, V. Bey, L. Pernar, and K.G. Commons Substance P acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity J. Neurosci. 23 2003 7155 7159
60. C.P. Vandermaelen, and G.K. Aghajanian Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices Brain Res. 289 1983 109 119
61. A. Zocchi, G. Varnier, R. Arban, C. Griffante, L. Zanetti, L. Bettelini, M. Marchi, P.A. Gerrardm, and M. Corsi Effects of antidepressant drugs and GR 205171, a neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse Neurosci. Lett. 345 2003 73 76